EMA publishes SmPC guidance for drug makers
This article was originally published in SRA
Executive Summary
The European Medicines Agency has published guidance designed to help drug companies ensure that the information in their summaries of product characteristics (SmPCs) is of high quality when they submit them to the agency as part of their marketing applications1.